Preclinical data showed promise in both systemic sclerosis bleomycin-induced mouse models and in patient-derived skin fibroblasts treated with EYD-001. The Food and Drug Administration (FDA) has ...

Several studies have evaluated patch testing for the diagnosis of drug eruptions, but widespread acceptance of this procedure is lacking in North America. The objective of this review is to address ...

Over the past two decades, antibody drug conjugates have been tested in clinical trials and approved for use in patients. Researchers recently performed a comprehensive analysis of multiple scientific ...